T5	Effect 0 4	ARDS
T7	Treatment 30 132	the administration of other monoclonal antibodies, such as infliximab, gemtuzumab ozogamicin, and OKT3
T8	Drug 89 99	infliximab
T9	Drug 101 111	gemtuzumab
T10	Drug 112 122	ozogamicin
T11	Drug 128 132	OKT3
T6	Adverse_event 14 24	associated
E1	Adverse_event:T6